Ronan P. Kelly
Singapore, 138623, Singapore
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Long-acting GIPR agonist LY3537021 reduces body weight and fasting blood glucose in patients with T2D: Preclinical development and phase 1 randomized ascending dose studies.
Journal: Molecular metabolism
Published: September 25, 2025
Effect of Gastric pH on the Pharmacokinetics of Atorvastatin and its Metabolites in Healthy Participants.
Journal: European journal of drug metabolism and pharmacokinetics
Published: January 27, 2025
Erratum. Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies. Diabetes Care 2016;39:1241-1249.
Journal: Diabetes care
Published: April 20, 2017
Once-weekly dulaglutide 1.5 mg restores insulin secretion in response to intravenous glucose infusion.
Journal: Diabetes, obesity & metabolism
Published: September 13, 2016
Evaluation of Efficacy and Safety of the Glucagon Receptor Antagonist LY2409021 in Patients With Type 2 Diabetes: 12- and 24-Week Phase 2 Studies.
Journal: Diabetes care
Published: July 27, 2015
Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants.
Journal: British journal of clinical pharmacology
Published: June 22, 2011
Lack of effect of acute oral ingestion of vitamin C on oxidative stress, arterial stiffness or blood pressure in healthy subjects.
Journal: Free radical research
Published: May 20, 2008
Showing 1-8 of 8
Last Updated: 09/26/2026